Skip to main content

J. Goldman & Co LP

Position in MGTX — MeiraGTx Holdings plc

CIK 1412741 NEW YORK, NY

Position in MGTX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,785,778
-$755,733 QoQ
Shares Held
206,210
-35.5% QoQ
Ownership
0.223%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in MGTX Over Time

Shares Held

Position Value (USD)

Derivatives in MGTX

reported options exposure · as of Jun 30, 2025
CallValue
$69,764
CallShares
10,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

J. Goldman & Co LP holds $186,588,929 across 52 Biotechnology names. MGTX ranks #22 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MGTX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,785,778 206,210
2025-12-31 $2,541,511 319,687
2025-09-30 $14,821,662 1,800,931
2025-06-30 $13,330,622 2,044,574
2025-06-30 $69,764 10,700
2025-03-31 $1,041,408 153,600
2025-03-31 $7,856,399 1,158,761
2024-12-31 $1,655,871 271,900
2024-12-31 $3,352,666 550,520
2024-09-30 $3,583,193 859,279
2024-06-30 $1,641,580 389,924
2024-03-31 $819,450 135,000